These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15154280)

  • 1. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.
    Mehendale SR; Bauer BA; Yuan CS
    Am J Chin Med; 2004; 32(1):1-10. PubMed ID: 15154280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
    Haller CA; Benowitz NL
    N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the potential risks associated with ephedra use: a review of recent efforts.
    Schulman S
    Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.
    Matsumoto K; Mikoshiba H; Saida T
    J Am Acad Dermatol; 2003 Apr; 48(4):628-30. PubMed ID: 12664035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
    Gurley BJ; Steelman SC; Thomas SL
    Clin Ther; 2015 Feb; 37(2):275-301. PubMed ID: 25262198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.
    Haller CA; Duan M; Benowitz NL; Jacob P
    J Anal Toxicol; 2004 Apr; 28(3):145-51. PubMed ID: 15107143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ma Huang, from dietary supplement to abuse].
    Arditti J; Bourdon JH; Spadari M; de Haro L; Richard N; Valli M
    Acta Clin Belg; 2002; 57 Suppl 1():34-6. PubMed ID: 11974441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of polymerase chain reaction (PCR) for the identification of ephedra DNA in dietary supplements.
    Techen N; Khan IA; Pan Z; Scheffler BE
    Planta Med; 2006 Feb; 72(3):241-7. PubMed ID: 16534729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric symptoms associated with ephedra use.
    Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P
    Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free".
    Gregory PJ
    J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of ischemic colitis associated with the herbal food supplement ma huang.
    Song HJ; Shim KN; Ryu KH; Kim TH; Jung SA; Yoo K
    Yonsei Med J; 2008 Jun; 49(3):496-9. PubMed ID: 18581601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids.
    Jacob P; Haller CA; Duan M; Yu L; Peng M; Benowitz NL
    J Anal Toxicol; 2004 Apr; 28(3):152-9. PubMed ID: 15107144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement.
    Sultan S; Spector J; Mitchell RM
    Mayo Clin Proc; 2006 Dec; 81(12):1630-1. PubMed ID: 17165643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chemical fingerprinting: application to Ephedra.
    Schaneberg BT; Crockett S; Bedir E; Khan IA
    Phytochemistry; 2003 Mar; 62(6):911-8. PubMed ID: 12590118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banning ephedra: good call, poor vision.
    Gordon JS
    Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
    [No Abstract]   [Full Text] [Related]  

  • 17. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible case of mania associated with ma-huang.
    Boerth JM; Caley CF
    Pharmacotherapy; 2003 Mar; 23(3):380-3. PubMed ID: 12627938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003.
    Tam JW; Dennehy CE; Ko R; Tsourounis C
    J Herb Pharmacother; 2006; 6(2):1-19. PubMed ID: 17182481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure activity and unresponsiveness after hydroxycut ingestion.
    Kockler DR; McCarthy MW; Lawson CL
    Pharmacotherapy; 2001 May; 21(5):647-51. PubMed ID: 11349754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.